Known Sources of Neuromins® DHA 200mg
DHA in a dose of 600 mg twice a day has been recommended for most adult patients with typical retinitis pigmentosa who are starting vitamin A palmitate 15,000 IU/day for the first time (see Berson et al; Archives of Ophthalmology 122: 1306-1314, 2004). Patients with retinitis pigmentosa should consult with their doctor concerning whether DHA is appropriate for them before ordering this supplement.
Neuromins® DHA 200 was the form of DHA used in this study. Neuromins® DHA 200 is available in many health food stores across the country. Brands of Neuromins® DHA 200 include Nature’s Way, Source Naturals, Solaray, Natrol, and Solgar. The above brands are sold directly to retail stores and clearing houses (two listed below) rather than to individual consumers. However, both Nature’s Way (1-800-962-8873 or www.naturesway.com) and Natrol (1-800-262-8765 or www.natrol.com) will help you locate a local supplier. The dose recommended is 600 mg twice each day (3 in the AM and 3 in the PM with meals) only for 2 years. Therefore, patients ordering Neuromins® DHA 200 will be taking six softgels per day. For example, a one-month supply would be 180 softgels and patients should plan accordingly. The following are sources of Neuromins® DHA 200 readily accessible by toll-free phone or via their websites.
SWANSON HEALTH PRODUCTS
P.O. Box 6003
Fargo, ND 58108-6003
(search Neuromins® on the homepage)
30 softgels (SWU092) 200mg
Shipping & Handling 4.95
Ship abroad for additional fee.
THE VITAMIN SHOPPE
Customer Care Department
2101 91st Street
North Bergen, NJ07047
(search Neuromins® on the
60 softgels (SR-5558) 200mg
120 softgels (SR-5559) 200mg
Shipping & Handling 4.99
Ship abroad with restrictions for added fee
Precautions: Please be reminded that DHA supplementation in a dose of 600 mg twice a day for adults with typical retinitis pigmentosa (RP) on vitamin A palmitate was reported to be effective for only two years and only in patients starting vitamin A for the first time. The products described above in this dose have not been tested or evaluated to determine their safety or effectiveness in children or adolescents with RP.
Stopping instructions: This dose of DHA should not be continued beyond two years because no evidence was found of a continued benefit and also because a slight tendency toward adversity on ocular function was observed over the longer term among patients on vitamin A palmitate 15,000 IU/day (see Archives of Ophthalmology, Volume 122, pages 1306-1314, 2004). This supplement in combination with vitamin A palmitate should not be taken by women who are pregnant or planning to become pregnant because of an increased risk of birth defects among women on high dose vitamin A intake.
Disclaimer: The listing of these suppliers and their products should not be misinterpreted as a recommendation or indication of proprietary interest in any of these companies.